2025. Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model. International Journal of Environmental Sciences. 11, 12s (Jun. 2025), 1360–1367. DOI:https://doi.org/10.64252/8crhea08.